Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00695318 · ClinicalTrials.gov registry record · Phase 2
Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy
A Phase 2 study, sponsored by Alimera Sciences.
- Terminated
- Registry status
- Phase 2
- Development phase
- 17
- Enrollment target
NCT00695318 is a Phase 2 study that was terminated before completion, run by Alimera Sciences. The registered enrollment target is 17 participants.
The verdict
NCT00695318, a Phase 2 study, was terminated before completion, sponsored by Alimera Sciences.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 17 participants
- Enrollment target
Study Summary
This study will compare the safety and efficacy of Medidur FA treatment in one eye to the sham-treated fellow eye of subjects with geographic atrophy secondary to AMD.
Interventions
- DRUG Fluocinolone Acetonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2008-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00695318
The ClinicalTrials.gov registry entry for NCT00695318 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alimera Sciences, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluocinolone Acetonide is the first listed.
NCT00695318 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00695318 about?
NCT00695318 is a clinical study titled "Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy". This study will compare the safety and efficacy of Medidur FA treatment in one eye to the sham-treated fellow eye of subjects with geographic atrophy secondary to AMD.
What is the current status of trial NCT00695318?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2008-12.
What interventions are being tested in trial NCT00695318?
The interventions under investigation include: Fluocinolone Acetonide (DRUG).
Who is sponsoring clinical trial NCT00695318?
This trial is sponsored by Alimera Sciences, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.